Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression

Area of Science:

• Microbiology
• Molecular Biology
• Drug Discovery

Background:

• Identifying novel antibacterial targets requires understanding if their inactivation causes bacterial death (bactericidal) or growth arrest (bacteriostatic).
• This distinction is crucial for developing effective anti-tubercular agents, especially for slow-growing mycobacteria.
• Conditional gene inactivation is a key method to assess target lethality.

Purpose of the Study:

• To develop and validate a mycobacteria-specific antisense gene inhibition system.
• To differentiate between bacteriostatic and bactericidal essential genes in mycobacteria.
• To identify potential novel high-value antibacterial targets.

Main Methods:

• Development of a mycobacteria-specific isopropyl $\beta$-D-1-thiogalactopyranoside (IPTG) inducible antisense expression vector system.
• Monitoring bacterial survival kinetics following antisense-mediated gene silencing of essential mycobacterial genes.
• Validation of target specificity using an auxotrophic gene (ilvB) and conditional media supplementation.

Main Results:

• The antisense system successfully differentiated between bacteriostatic (e.g., FtsZ) and bactericidal (e.g., inhA, rpoB/C, gyrA/B) essential genes.
• Genes targeted by existing anti-tubercular drugs (isoniazid, rifampicin, fluoroquinolones) were confirmed as bactericidal.
• Antisense inhibition of the ilvB gene showed reversible bactericidal activity upon supplementation with essential amino acids, confirming target specificity.

Conclusions:

• The developed IPTG-inducible antisense vector system is a valuable tool for functional genomics in mycobacteria.
• This system enables the classification of essential genes as bacteriostatic or bactericidal, aiding in the prioritization of novel antibacterial drug targets.
• The findings provide a foundation for identifying and validating new therapeutic strategies against mycobacterial infections, including tuberculosis.